Royal Fund Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$566K	Buy	21,376 +485	+2%	+$12.9K	0.06%	202
2025 Q1	$505K	Sell	20,891 -23,291	-53%	-$562K	0.06%	208
2024 Q4	$1.78M	Buy	44,182 +32,438	+276%	+$1.31M	0.17%	127
2024 Q3	$744K	Buy	11,744 +344	+3%	+$21.8K	0.04%	206
2024 Q2	$604K	Buy	+11,400	New	+$604K	0.05%	195